181 related articles for article (PubMed ID: 6397502)
21. Poorly controlled type I diabetes mellitus in young men selectively suppresses luteinizing hormone secretory burst mass.
López-Alvarenga JC; Zariñán T; Olivares A; González-Barranco J; Veldhuis JD; Ulloa-Aguirre A
J Clin Endocrinol Metab; 2002 Dec; 87(12):5507-15. PubMed ID: 12466346
[TBL] [Abstract][Full Text] [Related]
22. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in the human male. III. Effects of long term combined treatment with GnRH agonist and androgen.
Bhasin S; Heber D; Steiner BS; Handelsman DJ; Swerdloff RS
J Clin Endocrinol Metab; 1985 May; 60(5):998-1003. PubMed ID: 3920237
[TBL] [Abstract][Full Text] [Related]
23. Episodic luteinizing hormone (LH) secretion and the response of LH and follicle-stimulating hormone to LH-releasing hormone in aged men: evidence for coexistent primary testicular insufficiency and an impairment in gonadotropin secretion.
Winters SJ; Troen P
J Clin Endocrinol Metab; 1982 Sep; 55(3):560-5. PubMed ID: 6808008
[TBL] [Abstract][Full Text] [Related]
24. Impotence associated with low biological to immunological ratio of luteinizing hormone in a man with a pituitary stone.
Plourde PV; Dufau M; Plourde N; Santen RJ
J Clin Endocrinol Metab; 1985 Apr; 60(4):797-802. PubMed ID: 3882739
[TBL] [Abstract][Full Text] [Related]
25. Concordant suppression of serum immunoreactive luteinizing hormone (LH), follicle-stimulating hormone, alpha subunit, bioactive LH, and testosterone in postmenopausal women by a potent gonadotropin releasing hormone antagonist (detirelix).
Andreyko JL; Monroe SE; Marshall LA; Fluker MR; Nerenberg CA; Jaffe RB
J Clin Endocrinol Metab; 1992 Feb; 74(2):399-405. PubMed ID: 1370507
[TBL] [Abstract][Full Text] [Related]
26. Differential responses of biologically active luteinizing hormone secretion in older versus young men to interruption of androgen negative feedback.
Veldhuis JD; Urban RJ; Dufau ML
J Clin Endocrinol Metab; 1994 Dec; 79(6):1763-70. PubMed ID: 7989483
[TBL] [Abstract][Full Text] [Related]
27. Low serum bioactive luteinizing hormone in nonorganic male impotence: possible relationship with altered gonadotropin-releasing hormone pulsatility.
Fabbri A; Jannini EA; Ulisse S; Gnessi L; Moretti C; Frajese G; Isidori A
J Clin Endocrinol Metab; 1988 Nov; 67(5):867-75. PubMed ID: 3141450
[TBL] [Abstract][Full Text] [Related]
28. Preferential release of bioactive luteinizing hormone in response to endogenous and low dose exogenous gonadotropin-releasing hormone pulses in man.
Veldhuis JD; Johnson ML; Dufau ML
J Clin Endocrinol Metab; 1987 Jun; 64(6):1275-82. PubMed ID: 3553222
[TBL] [Abstract][Full Text] [Related]
29. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.
Fauser BC; Pache TD; Lamberts SW; Hop WC; de Jong FH; Dahl KD
J Clin Endocrinol Metab; 1991 Oct; 73(4):811-7. PubMed ID: 1909705
[TBL] [Abstract][Full Text] [Related]
30. Age-related decrease in hypothalamic gonadotropin-releasing hormone (GnRH) gene expression, but not pituitary responsiveness to GnRH, in the male Brown Norway rat.
Gruenewald DA; Naai MA; Marck BT; Matsumoto AM
J Androl; 2000; 21(1):72-84. PubMed ID: 10670522
[TBL] [Abstract][Full Text] [Related]
31. Naloxone increases bioactive LH in man: evidence for selective release of early LH pool.
Fraioli F; Fabbri A; Gnessi L; Moretti C; Bonifacio V; Isidori A; Dufau M
J Endocrinol Invest; 1985 Dec; 8(6):513-7. PubMed ID: 3914504
[TBL] [Abstract][Full Text] [Related]
32. Effects of decreasing the frequency of gonadotropin-releasing hormone stimulation on gonadotropin secretion in gonadotropin-releasing hormone-deficient men and perifused rat pituitary cells.
Finkelstein JS; Badger TM; O'Dea LS; Spratt DI; Crowley WF
J Clin Invest; 1988 Jun; 81(6):1725-33. PubMed ID: 3290251
[TBL] [Abstract][Full Text] [Related]
33. Aging in healthy men impairs recombinant human luteinizing hormone (LH)-stimulated testosterone secretion monitored under a two-day intravenous pulsatile LH clamp.
Liu PY; Takahashi PY; Roebuck PD; Iranmanesh A; Veldhuis JD
J Clin Endocrinol Metab; 2005 Oct; 90(10):5544-50. PubMed ID: 16030163
[TBL] [Abstract][Full Text] [Related]
34. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
[TBL] [Abstract][Full Text] [Related]
35. Pulsatile intravenous gonadotropin-releasing hormone administration averts fasting-induced hypogonadotropism and hypoandrogenemia in healthy, normal weight men.
Aloi JA; Bergendahl M; Iranmanesh A; Veldhuis JD
J Clin Endocrinol Metab; 1997 May; 82(5):1543-8. PubMed ID: 9141547
[TBL] [Abstract][Full Text] [Related]
36. LH measurements by in vitro bioassay and a highly sensitive immunofluorometric assay improve the distinction between boys with constitutional delay of puberty and hypogonadotropic hypogonadism.
Haavisto AM; Dunkel L; Pettersson K; Huhtaniemi I
Pediatr Res; 1990 Mar; 27(3):211-4. PubMed ID: 2181393
[TBL] [Abstract][Full Text] [Related]
37. Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men.
Pavlou SN; Wakefield G; Schlechter NL; Lindner J; Souza KH; Kamilaris TC; Konidaris S; Rivier JE; Vale WW; Toglia M
J Clin Endocrinol Metab; 1989 Feb; 68(2):446-54. PubMed ID: 2537334
[TBL] [Abstract][Full Text] [Related]
38. Effects of luteinizing hormone releasing hormone (LHRH) upon bioactive and immunoreactive serum LH levels in normal subjects.
Dufau ML; Beitins IZ; McArthur JW; Catt KJ
J Clin Endocrinol Metab; 1976 Sep; 43(3):658-67. PubMed ID: 783183
[TBL] [Abstract][Full Text] [Related]
39. Aging attenuates both the regularity and joint synchrony of LH and testosterone secretion in normal men: analyses via a model of graded GnRH receptor blockade.
Liu PY; Pincus SM; Takahashi PY; Roebuck PD; Iranmanesh A; Keenan DM; Veldhuis JD
Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E34-E41. PubMed ID: 16339924
[TBL] [Abstract][Full Text] [Related]
40. Sex steroid control of gonadotropin secretion in the human male. I. Effects of testosterone administration in normal and gonadotropin-releasing hormone-deficient men.
Finkelstein JS; Whitcomb RW; O'Dea LS; Longcope C; Schoenfeld DA; Crowley WF
J Clin Endocrinol Metab; 1991 Sep; 73(3):609-20. PubMed ID: 1908484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
